Antibodies generated in vitro and in vivo elucidate design of a thermostable ADDomer COVID-19 nasal nanoparticle vaccine (2023)
Attributed to:
The UK High-End Computing Consortium for Biomolecular Simulation
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2023.03.17.533092
Publication URI: http://dx.doi.org/10.1101/2023.03.17.533092
Type: Preprint